These findings and the recognized role of inflammation and microbiota in the initiation and progression of CRC prompted us to investigate the expression and role of NHE3 in human colon cancer and in a defined mouse model of CRC. This evidence concerns the gene SLC9A3 and malignant colon neoplasm.